Tan, T, Shaw, VR
ORCID: 0000-0002-1172-5686, Byun, J, Lee, HS, Han, Y, Li, Y, Hung, RJ, Christiani, DC, Wang, XA, Johansson, M et al (show 31 more authors)
(2026)
Germline HLA heterozygosity is associated with decreased lung cancer risk
Human Genetics and Genomics Advances, 7 (2).
100567-.
ISSN 2666-2477, 2666-2477
Abstract
Heterozygosity at human leukocyte antigen ( HLA ) loci may improve lung cancer immunosurveillance by increasing recognition of the tumor by the immune system. Previous studies utilizing data from population-level biobanks, such as the United Kingdom Biobank and FinnGen, have identified an association between germline HLA class II ( HLA- II) heterozygosity and reduced lung cancer risk in smokers. In the present study, we evaluate the association between HLA heterozygosity and lung cancer in a large case-control study (15,302 cases and 14,580 controls) with imputed HLA allele-type information, comparing differences in HLA heterozygosity between smokers and non-smokers, among lung cancer subtypes, and at 2- and 4-digit HLA allele resolution. We identify a strong protective association of HLA -II heterozygosity in smokers compared to non-smokers, particularly at the HLA-DPB1 and HLA-DPA1 loci, and provide subtype-specific resolution. Finally, analysis of the additive effects of HLA allele heterozygosity in smokers identified significant associations with several 4-digit HLA alleles, including HLA-B∗08 : 01 , HLA-A∗01 : 01 , HLA-C∗07 : 01 , HLA-DQA1∗05 : 01 , HLA-DRB1∗03 : 01 , and HLA-C∗03 : 04 . Our study provides additional evidence, with added histologic subtype information, that germline HLA -II heterozygosity is inversely associated with lung cancer risk.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | HLA, genetic risk, genetics, lung cancer, smoking, Humans, Lung Neoplasms, Genetic Predisposition to Disease, Heterozygote, Case-Control Studies, Male, HLA Antigens, Female, Alleles, Middle Aged, Aged, Smoking, Risk Factors |
| Divisions: | Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Molecular & Clinical Cancer Medicine |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 02 Feb 2026 16:56 |
| Last Modified: | 11 Apr 2026 19:01 |
| DOI: | 10.1016/j.xhgg.2026.100567 |
| Open Access URL: | https://doi.org/10.1016/j.xhgg.2026.100567 |
| Related Websites: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3196839 |
| Disclaimer: | The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate. |
Altmetric
Altmetric